BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4384615)

  • 1. The influences of drugs on the uptake of 5-hydroxytryptamine by nerve-ending particles of rabbit brain stem.
    Segawa T; Kuruma I
    J Pharm Pharmacol; 1968 Apr; 20(4):320-2. PubMed ID: 4384615
    [No Abstract]   [Full Text] [Related]  

  • 2. The influences of drugs on the uptake of 5-hydroxytryptamine by synaptic vesicles of rabbit brain stem.
    Segawa T; Kuruma I; Takatsuka K; Takagi H
    J Pharm Pharmacol; 1968 Oct; 20(10):800-1. PubMed ID: 4386752
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of reserpine and desipramine on the uptake and subcellular distribution of 5-hydroxytryptamine in rabbit brain stem after intravenous administration of 5-hydroxytryptophan.
    Segawa T
    Jpn J Pharmacol; 1970 Mar; 20(1):87-91. PubMed ID: 4393817
    [No Abstract]   [Full Text] [Related]  

  • 4. Uptake and storage mechanism of 5-hydroxytryptamine in rabbit brain stem and effect of reserpine.
    Takatsuka K; Segawa T; Takagi H
    Jpn J Pharmacol; 1971 Feb; 21(1):57-67. PubMed ID: 4403263
    [No Abstract]   [Full Text] [Related]  

  • 5. Accumulation of tritiated 5-hydroxytryptamine in brain slices.
    Ross SB; Renyl AL
    Life Sci; 1967 Jul; 6(13):1407-15. PubMed ID: 4382451
    [No Abstract]   [Full Text] [Related]  

  • 6. Localization of 5-hydroxytryptamine uptake in rat brain after intraventricular injection.
    Fuxe K; Ungerstedt U
    J Pharm Pharmacol; 1967 May; 19(5):335-7. PubMed ID: 4382408
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug induced changes in the distribution of 14C5-HT in the pithed reserpinized rat.
    Fozard JR
    Eur J Pharmacol; 1969 Sep; 7(3):248-57. PubMed ID: 4390870
    [No Abstract]   [Full Text] [Related]  

  • 8. Influences of intraventricularly administered 5-hydroxytryptamine on normal and amine-depleted rabbit: subcellular distribution of 5-hydroxytryptamine in the brain stem, and animal behaviour.
    Segawa T; Fujisawa T
    Biochem Pharmacol; 1972 May; 21(9):1357-67. PubMed ID: 4261028
    [No Abstract]   [Full Text] [Related]  

  • 9. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles.
    Marchbanks RM
    Biochem Pharmacol; 1967 Oct; 16(10):1971-9. PubMed ID: 6065963
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue.
    Ross SB; Renyi AL
    Eur J Pharmacol; 1969 Sep; 7(3):270-7. PubMed ID: 5351984
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcellular distribution and chemical nature of the receptor for 5-hydroxytryptamine in the central nervous system.
    Fiszer S; De Robertis E
    J Neurochem; 1969 Aug; 16(8):1201-9. PubMed ID: 5803796
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of cocaine and desmethylimipramine on the uptake, retention and metabolism of 3H-5-hydroxytryptamine in rat brain slices.
    Yu JH; Smith CB
    Pharmacology; 1977; 15(3):242-53. PubMed ID: 866402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-hydroxytryptamine uptake by rat brain in vitro.
    Blackburn KJ; French PC; Merrills RJ
    Life Sci; 1967 Aug; 6(15):1653-63. PubMed ID: 5299290
    [No Abstract]   [Full Text] [Related]  

  • 15. Uptake of nicotine by the sympathetic nerve terminals in the blood vessel.
    Bevan JA; Su C
    J Pharmacol Exp Ther; 1972 Sep; 182(3):419-26. PubMed ID: 5055404
    [No Abstract]   [Full Text] [Related]  

  • 16. On the ability of desipramine to interfere with reserpine-induced noradrenaline release.
    Manara L; Sestini MG; Algeri S; Garattini S
    J Pharm Pharmacol; 1966 Mar; 18(3):194-5. PubMed ID: 4381219
    [No Abstract]   [Full Text] [Related]  

  • 17. Removal of 5-hydroxytryptamine by rat isolated lung.
    Alabaster VA; Bakhle YS
    Br J Pharmacol; 1970 Feb; 38(2):440P-441P. PubMed ID: 5417869
    [No Abstract]   [Full Text] [Related]  

  • 18. An in vitro study of the effects of tricyclic antidepressant drugs on the accumulation of C14-serotonin by rabbit brain.
    Alpers HS; Himwich HE
    Biol Psychiatry; 1969 Jan; 1(1):81-5. PubMed ID: 5367323
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the physiologic disposition and activity of phenylpropanolamines in the mouse.
    Levitt M; Cumiskey WR; Shargel L
    Drug Metab Dispos; 1974; 2(2):187-93. PubMed ID: 4150999
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective storage of p-hydroxy-d-amphetamine in the dopaminergic nerve terminals.
    Jori A; Caccia S; Guiso A; Ballabio M; Garattini S
    Biochem Pharmacol; 1979 Apr; 28(7):1205-7. PubMed ID: 444278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.